Show Search Form

Search Results

human indexable	true false
published	true false
registered interest	true false
answer date	exactly: or between: and
date	exactly: or between: and
date tabled	exactly: or between: and
ddp created	exactly: or between: and
answering body
question status
answering dept id
answering dept short name
answering dept sort name
ddp modified
hansard heading
house id
identifier
legislature	pref label
parliament number
question first answered
question text
session
session number
tabling member constituency
tabling member printed
title
type
uin
version
written parliamentary question type
answer	answering member label
creator	label
publisher	pref label
tabling member	label

Search

1008480

	human indexable
	published
	registered interest
	answer date	20/11/2018
	date	16/11/2018
	date tabled	16/11/2018
	ddp created	16/11/2018 15:26:07
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	16/11/2018 15:37:17 26/11/2018 18:15:04
	hansard heading	Diabetes: Medical Equipment
	house id	1
	identifier	192109
	legislature	25259 pref label House of Commons
	parliament number	57
	question first answered	26/11/2018 17:43:55
	question text	To ask the Secretary of State for Health and Social Care, what estimate his Department has made of the potential savings to the NHS of making flash glucose monitoring technology available to all patients with diabetes across NHS clinical commissioning groups.
	session	2017/19
	session number	1
	tabling member constituency	York Outer
	tabling member printed	Julian Sturdy
	title	House of Commons Tabled Parliamentary Question 2017/19 192109
	type	WrittenParliamentaryQuestion
	uin	192109
	version	1
	written parliamentary question type	Ordinary
	answer	answer answering member 4067 label Biography information for Steve Brine
	creator	4079 label Biography information for Julian Sturdy
	publisher	25259 pref label House of Commons
	tabling member	4079 label Biography information for Julian Sturdy

1008479

	human indexable
	published
	registered interest
	answer date	20/11/2018
	date	16/11/2018
	date tabled	16/11/2018
	ddp created	16/11/2018 15:26:04
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	16/11/2018 15:37:15 26/11/2018 18:15:06
	hansard heading	Diabetes: Medical Equipment
	house id	1
	identifier	192108
	legislature	25259 pref label House of Commons
	parliament number	57
	question first answered	26/11/2018 17:43:55
	question text	To ask the Secretary of State for Health and Social Care, whether he plans to make flash glucose monitoring technology available to all patients with diabetes across clinical commissioning groups.
	session	2017/19
	session number	1
	tabling member constituency	York Outer
	tabling member printed	Julian Sturdy
	title	House of Commons Tabled Parliamentary Question 2017/19 192108
	type	WrittenParliamentaryQuestion
	uin	192108
	version	1
	written parliamentary question type	Ordinary
	answer	answer answering member 4067 label Biography information for Steve Brine
	creator	4079 label Biography information for Julian Sturdy
	publisher	25259 pref label House of Commons
	tabling member	4079 label Biography information for Julian Sturdy

1008485

	human indexable
	published
	registered interest
	answer date	20/11/2018
	date	16/11/2018
	date tabled	16/11/2018
	ddp created	16/11/2018 15:26:18
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	16/11/2018 15:37:28 26/11/2018 18:15:08
	hansard heading	Obesity: Children
	house id	1
	identifier	192128
	legislature	25259 pref label House of Commons
	parliament number	57
	question first answered	26/11/2018 17:43:16
	question text	To ask the Secretary of State for Health and Social Care, with reference to Chapter 2 of the Childhood obesity: a plan for action, published in June 2018, whether the consultation on a 9pm watershed on TV advertising of junk food products is planned to be published by the end of 2018.
	session	2017/19
	session number	1
	tabling member constituency	Leicester South
	tabling member printed	Jonathan Ashworth
	title	House of Commons Tabled Parliamentary Question 2017/19 192128
	type	WrittenParliamentaryQuestion
	uin	192128
	version	1
	written parliamentary question type	Ordinary
	answer	answer answering member 4067 label Biography information for Steve Brine
	creator	4244 label Biography information for Jonathan Ashworth
	publisher	25259 pref label House of Commons
	tabling member	4244 label Biography information for Jonathan Ashworth

1007919

	human indexable
	published
	registered interest
	answer date	29/11/2018
	date	15/11/2018
	date tabled	15/11/2018
	ddp created	15/11/2018 20:23:29
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	15/11/2018 20:25:34 29/11/2018 17:36:15
	hansard heading	Vaccination: Research
	house id	2
	identifier	HL11528
	legislature	25277 pref label House of Lords
	parliament number	57
	question first answered	29/11/2018 17:04:03
	question text	To ask Her Majesty's Government what support they are providing for (1) vaccine research, and (2) the development of cheaper versions of existing vaccines.
	session	2017/19
	session number	1
	tabling member printed	Baroness Kennedy of Cradley
	title	House of Lords Tabled Parliamentary Question 2017/19 HL11528
	type	WrittenParliamentaryQuestion
	uin	HL11528
	version	1
	written parliamentary question type	Ordinary
	answer	answer answering member 4545 label Biography information for Lord O'Shaughnessy
	creator	4303 label Biography information for Baroness Kennedy of Cradley
	publisher	25277 pref label House of Lords
	tabling member	4303 label Biography information for Baroness Kennedy of Cradley

1007918

	human indexable
	published
	registered interest
	answer date	29/11/2018
	date	15/11/2018
	date tabled	15/11/2018
	ddp created	15/11/2018 20:23:27
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	15/11/2018 20:25:32 29/11/2018 17:35:05
	hansard heading	Medicine: Research
	house id	2
	identifier	HL11527
	legislature	25277 pref label House of Lords
	parliament number	57
	question first answered	29/11/2018 17:03:35
	question text	To ask Her Majesty's Government what assessment they have made of work being undertaken to create synthetic cells.
	session	2017/19
	session number	1
	tabling member printed	Baroness Kennedy of Cradley
	title	House of Lords Tabled Parliamentary Question 2017/19 HL11527
	type	WrittenParliamentaryQuestion
	uin	HL11527
	version	1
	written parliamentary question type	Ordinary
	answer	answer answering member 4545 label Biography information for Lord O'Shaughnessy
	creator	4303 label Biography information for Baroness Kennedy of Cradley
	publisher	25277 pref label House of Lords
	tabling member	4303 label Biography information for Baroness Kennedy of Cradley

1007513

	human indexable
	published
	registered interest
	answer date	28/11/2018
	date	14/11/2018
	date tabled	14/11/2018
	ddp created	14/11/2018 21:42:55
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	14/11/2018 21:46:05 28/11/2018 17:53:01
	hansard heading	Carers
	house id	2
	identifier	HL11511
	legislature	25277 pref label House of Lords
	parliament number	57
	question first answered	28/11/2018 17:21:15
	question text	To ask Her Majesty's Government what measures will be included in the NHS Long Term Plan to ensure that unpaid carers are (1) identified, and (2) offered support.
	session	2017/19
	session number	1
	tabling member printed	Baroness Pitkeathley
	title	House of Lords Tabled Parliamentary Question 2017/19 HL11511
	type	WrittenParliamentaryQuestion
	uin	HL11511
	version	1
	written parliamentary question type	Ordinary
	answer	answer answering member 4545 label Biography information for Lord O'Shaughnessy
	creator	3179 label Biography information for Baroness Pitkeathley
	publisher	25277 pref label House of Lords
	tabling member	3179 label Biography information for Baroness Pitkeathley

1007503

	human indexable
	published
	registered interest
	answer date	28/11/2018
	date	14/11/2018
	date tabled	14/11/2018
	ddp created	14/11/2018 21:42:42
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	14/11/2018 21:45:48 28/11/2018 15:23:03
	hansard heading	Cancer
	house id	2
	identifier	HL11503
	legislature	25277 pref label House of Lords
	parliament number	57
	question first answered	28/11/2018 14:51:55
	question text	To ask Her Majesty's Government how the UK's (1) one year, and (2) five year cancer survival rates compare to (a) France, (b) Germany, (c) Belgium, and (d) Sweden, as reported in international comparisons such as Eurocare-5; and what are the 20 cancers by incidence for which the difference in survival rates between the UK and other countries is greatest.
	session	2017/19
	session number	1
	tabling member printed	Lord Freyberg
	title	House of Lords Tabled Parliamentary Question 2017/19 HL11503
	type	WrittenParliamentaryQuestion
	uin	HL11503
	version	1
	written parliamentary question type	Ordinary
	answer	answer answering member 4545 label Biography information for Lord O'Shaughnessy
	creator	2593 label Biography information for Lord Freyberg
	publisher	25277 pref label House of Lords
	tabling member	2593 label Biography information for Lord Freyberg

1007502

	human indexable
	published
	registered interest
	answer date	28/11/2018
	date	14/11/2018
	date tabled	14/11/2018
	ddp created	14/11/2018 21:42:41
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	14/11/2018 21:45:46 28/11/2018 15:22:07
	hansard heading	Cancer: Screening
	house id	2
	identifier	HL11502
	legislature	25277 pref label House of Lords
	parliament number	57
	question first answered	28/11/2018 14:50:06
	question text	To ask Her Majesty's Government what assessment the Chief Scientific Adviser has made of the importance of molecular testing to drive modern cancer trial recruitment, and of the introduction of such testing for which cancers offer the most value to the UK in terms of driving clinical trial recruitment.
	session	2017/19
	session number	1
	tabling member printed	Lord Freyberg
	title	House of Lords Tabled Parliamentary Question 2017/19 HL11502
	type	WrittenParliamentaryQuestion
	uin	HL11502
	version	1
	written parliamentary question type	Ordinary
	answer	answer answering member 4545 label Biography information for Lord O'Shaughnessy
	creator	2593 label Biography information for Lord Freyberg
	publisher	25277 pref label House of Lords
	tabling member	2593 label Biography information for Lord Freyberg

1007501

	human indexable
	published
	registered interest
	answer date	28/11/2018
	date	14/11/2018
	date tabled	14/11/2018
	ddp created	14/11/2018 21:42:40
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	14/11/2018 21:45:44 28/11/2018 15:22:04
	hansard heading	Cancer: Screening
	house id	2
	identifier	HL11501
	legislature	25277 pref label House of Lords
	parliament number	57
	question first answered	28/11/2018 14:50:06
	question text	To ask Her Majesty's Government what assessment they have made of (1) the economic importance of clinical trial recruitment, especially in cancer research, to the UK economy, and (2) the importance of timely molecular testing in modern cancer trial recruitment; and whether, as a result of any such assessment, NHS England will consider implementing national somatic gene testing in cancers with low survival rates to catalyse research.
	session	2017/19
	session number	1
	tabling member printed	Lord Freyberg
	title	House of Lords Tabled Parliamentary Question 2017/19 HL11501
	type	WrittenParliamentaryQuestion
	uin	HL11501
	version	1
	written parliamentary question type	Ordinary
	answer	answer answering member 4545 label Biography information for Lord O'Shaughnessy
	creator	2593 label Biography information for Lord Freyberg
	publisher	25277 pref label House of Lords
	tabling member	2593 label Biography information for Lord Freyberg

1007498

	human indexable
	published
	registered interest
	answer date	28/11/2018
	date	14/11/2018
	date tabled	14/11/2018
	ddp created	14/11/2018 21:42:38
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	14/11/2018 21:45:41 28/11/2018 14:30:04
	hansard heading	Flour: Folic Acid
	house id	2
	identifier	HL11499
	legislature	25277 pref label House of Lords
	parliament number	57
	question first answered	28/11/2018 13:58:54
	question text	To ask Her Majesty's Government what assessment they have made of research into the impact of folic acid flour fortification on the development of neural tube defects, such as spina bifida.
	session	2017/19
	session number	1
	tabling member printed	Baroness Finlay of Llandaff
	title	House of Lords Tabled Parliamentary Question 2017/19 HL11499
	type	WrittenParliamentaryQuestion
	uin	HL11499
	version	1
	written parliamentary question type	Ordinary
	answer	answer answering member 4545 label Biography information for Lord O'Shaughnessy
	creator	3609 label Biography information for Baroness Finlay of Llandaff
	publisher	25277 pref label House of Lords
	tabling member	3609 label Biography information for Baroness Finlay of Llandaff